Bioqual Stock Performance
| BIOQ Stock | USD 43.19 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.12, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bioqual's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bioqual is expected to be smaller as well. At this point, Bioqual has a negative expected return of -0.37%. Please make sure to confirm Bioqual's variance and skewness , to decide if Bioqual performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Bioqual has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in August 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Total Cashflows From Investing Activities | -4.7 M |
Bioqual |
Bioqual Relative Risk vs. Return Landscape
If you would invest 5,500 in Bioqual on April 28, 2025 and sell it today you would lose (1,181) from holding Bioqual or give up 21.47% of portfolio value over 90 days. Bioqual is currently does not generate positive expected returns and assumes 1.3928% risk (volatility on return distribution) over the 90 days horizon. In different words, 12% of pink sheets are less volatile than Bioqual, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Bioqual Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioqual's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Bioqual, and traders can use it to determine the average amount a Bioqual's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2678
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BIOQ |
Estimated Market Risk
| 1.39 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.27 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bioqual is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioqual by adding Bioqual to a well-diversified portfolio.
Bioqual Fundamentals Growth
Bioqual Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Bioqual, and Bioqual fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bioqual Pink Sheet performance.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0688 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.1 % | |||
| Current Valuation | 1.48 M | |||
| Shares Outstanding | 896 K | |||
| Price To Earning | 13.03 X | |||
| Price To Sales | 0.96 X | |||
| Revenue | 67.96 M | |||
| EBITDA | 8.57 M | |||
| Cash And Equivalents | 2.18 M | |||
| Cash Per Share | 2.44 X | |||
| Total Debt | 18.72 M | |||
| Debt To Equity | 0.50 % | |||
| Book Value Per Share | 43.67 X | |||
| Cash Flow From Operations | 313.36 K | |||
| Earnings Per Share | 6.14 X | |||
| Total Asset | 5.05 M | |||
| Retained Earnings | (2.75 M) | |||
| Current Asset | 2.65 M | |||
| Current Liabilities | 985 K | |||
About Bioqual Performance
Assessing Bioqual's fundamental ratios provides investors with valuable insights into Bioqual's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Bioqual is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland. Bioqual operates under Diagnostics Research classification in the United States and is traded on OTC Exchange.Things to note about Bioqual performance evaluation
Checking the ongoing alerts about Bioqual for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Bioqual help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bioqual generated a negative expected return over the last 90 days |
- Analyzing Bioqual's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bioqual's stock is overvalued or undervalued compared to its peers.
- Examining Bioqual's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bioqual's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bioqual's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bioqual's pink sheet. These opinions can provide insight into Bioqual's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Bioqual Pink Sheet Analysis
When running Bioqual's price analysis, check to measure Bioqual's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioqual is operating at the current time. Most of Bioqual's value examination focuses on studying past and present price action to predict the probability of Bioqual's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioqual's price. Additionally, you may evaluate how the addition of Bioqual to your portfolios can decrease your overall portfolio volatility.